meRfi®-GM
Bacteroides fragilis
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
GenBankAC: FQ312004, CR626927, AP006841, AP006842, CR626928
Bacteroides fragilis belongs to the gram-negative and anaerobic species in the healthy human gut; the abundance is middle: about 3.47% of all species in the healthy human gut
Bacteroides fragilis is characterized by outer membrane vesicles that also contain pro-inflammatory molecules such as LPS
Bacteroides fragilis, which, depending on the strain, can induce either immunoregulation or [inflammation](brain://tVLLtMNKyEWRi0Em4dukRw/Inflammation…
References (Sources)
- Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer’s disease
- Baseline human gut microbiota profile in healthy people and standard reporting template
- Biotic/abiotic stress-driven Alzheimer’s disease
- Roles of intestinal bacteroides in human health and diseases
- Surveillance of Antimicrobial Susceptibility of Anaerobe Clinical Isolates in Southeast Austria: Bacteroides fragilis Group Is on the Fast Track to Resistance
- The gut microbiota shapes intestinal immune responses during health and disease.
- Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy